共病与髋部骨折患者住院医疗质量的关系
基于丹麦多学科髋部骨折登记库2014至2018年31,443例65岁及以上髋部骨折患者,采用Charlson共病指数评估共病水平,以指南推荐的住院流程指标全部达标率及单项达标率为结局。结果显示仅31%患者全部达标,高共病(Charlson≥3)者全部达标率29%,无共病者34%,高共病者全部达标的可能性降低15%(RR=0.85,95%CI 0.81-0.89)。
要点
- 髋部骨折患者住院流程指标全部达标率仅31%,整体质量有待提升。
- 高共病(Charlson≥3)患者全部达标率29%,低于无共病者的34%。
- 高共病者术前优化、早期手术和早期活动达标可能性低6%至11%。
核心结论
- 共病水平越高,髋部骨折患者住院医疗质量(流程指标达标率)越低。
- 结果提示需针对共病患者制定定制化临床措施,确保其从髋部骨折诊疗进展中获益。
研究设计与样本
- 基于丹麦多学科髋部骨折登记库(DMHFR)的人群队列研究,使用前瞻性收集数据。
- 纳入2014至2018年登记的65岁及以上新发髋部骨折患者,共31,443例。
- 共病采用基于医院诊断的Charlson共病指数测量,结局为全部相关流程指标全部达标及单项达标,采用二分类回归计算相对危险度(RR)。
主要发现
- 髋部骨折患者全部流程指标全部达标的总体比例为31%。
- 无共病患者全部达标率为34%,高共病(Charlson≥3)患者为29%,对应高共病者全部达标可能性降低15%(RR=0.85,95%CI 0.81-0.89)。
- 共病增加与单项流程指标达标率降低相关,差异最大者为术前优化、早期手术和早期活动,高共病者较无共病者达标可能性低6%至11%。
关键数值与推荐
- 流程指标包括术前优化、早期手术、早期活动、疼痛评估、基本活动能力、营养风险、抗骨质疏松药物需求、跌倒预防及出院后康复计划。
- 全部达标定义为所有相关流程指标均达标。
- 共病水平采用Charlson共病指数,高共病定义为Charlson≥3。
临床怎么用
- 对高共病髋部骨折患者应关注术前优化、早期手术和早期活动等流程的落实。
- 可考虑针对共病患者制定定制化临床措施,以减少流程达标差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We examined whether the comorbidity burden of patients with hip fracture was associated with quality of in-hospital care reflected by fulfillment of process performance measures. DESIGN: Population-based cohort study using prospectively collected data from the Danish Multidisciplinary Hip Fracture Registry (DMHFR). SETTING AND PARTICIPANTS: Patients aged 65 years or older with an incident hip fracture from 2014 to 2018 registered in the DMHFR (n = 31,443). METHODS: Comorbidity was measured using the Charlson Comorbidity Index based on hospital diagnoses. Quality of in-hospital care was defined as fulfillment of eligible process performance measures, including preoperative optimization, early surgery, early mobilization, pain assessment, basic mobility, nutritional risk, need for anti-osteoporotic medication, fall prevention, and a post-discharge rehabilitation program, reflecting guideline-recommended in-hospital care. The outcomes were (1) an all-or-none composite measure defined as fulfillment of all relevant process performance measures, and (2) fulfillment of the individual process performance measures. Using binary regression, we calculated relative risk (RR) for the association between comorbidity level and outcomes. RESULTS: The overall proportion of patients with hip fracture who fulfilled the all-or-none measure was 31%. Among patients with no comorbidity, 34% fulfilled the all-or-none measure versus 29% among patients with high comorbidity (Charlson ≥ 3). This corresponds to a 15% lower chance (RR = 0.85, 95% confidence interval 0.81-0.89). Increasing comorbidity was also associated with lower fulfillment of the individual process performance measures. The largest difference was seen for preoperative optimization, early surgery, and early mobilization, where patients with high comorbidity had 6% to 11% lower chance of fulfillment of these process performance measures compared with patients without comorbidity. CONCLUSION AND IMPLICATIONS: Increasing level of comorbidity was associated with lower quality of in-hospital care among patients with hip fracture. Our results highlight the need for tailored clinical initiatives to ensure that comorbid patients also benefit from the positive progress in hip fracture care in recent years.
引用
- Schrøder CK, Hjelholt TJ, Møller H, et al. Comorbidity and Quality of In-Hospital Care for Hip Fracture Patients. J Am Med Dir Assoc. 2022. PMID: 35247357. doi:10.1016/j.jamda.2022.01.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。